Quick Answer
Lexaria Bioscience Corp. reported Stockholders Equity of $2.99 million for fiscal year 2025.
Lexaria Bioscience Corp. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $2.99M | -62.8% |
| 2024 | $8.04M | +164.0% |
| 2023 | $3.04M | -61.7% |
| 2022 | $7.95M | -40.1% |
| 2021 | $13.27M | +434.4% |
| 2020 | $2.48M | -0.3% |
| 2019 | $2.49M | +4.3% |
| 2018 | $2.39M | -13.7% |
| 2017 | $2.77M | +940.4% |
| 2016 | $266.0K | -65.6% |
| 2015 | $772.4K | -55.0% |
| 2014 | $1.72M | -18.2% |
| 2013 | $2.10M | -13.3% |
| 2012 | $2.42M | -9.0% |
| 2011 | $2.66M | +23.6% |
| 2010 | $2.15M | -6.3% |
| 2009 | $2.30M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $4.91M | -49.7% | +64.3% |
| August 31, 2025 | $2.99M | -62.8% | -46.2% |
| May 31, 2025 | $5.55M | -45.2% | -22.3% |
| February 28, 2025 | $7.14M | +9.6% | -26.9% |
| November 30, 2024 | $9.77M | +161.2% | +21.6% |
| August 31, 2024 | $8.04M | +164.0% | -20.6% |
| May 31, 2024 | $10.12M | +130.3% | +55.2% |
| February 29, 2024 | $6.52M | +31.1% | +74.2% |
- Lexaria Bioscience Corp. showed a decrease of -62.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, Lexaria Bioscience Corp.’s stockholders equity has grown by 30.1% (from $2.30 million to $2.99 million).
- The most recent figure is from Lexaria Bioscience Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: